Quality project to evaluate and validate the FAST-O Rating Scale - FAST-O

Study identifier:NIS-NSE-DUM-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Quality project to Evaluate and Validate the FAST-O Rating Scale (Fast ASessment in acute Treatment of psychosis-Observation)

Medical condition

Acute Psychotic Symptoms

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

111

Study type

Observational

Age

N/A

Date

Study Start Date: 01 May 2009

Primary Completion Date: -

Study Completion Date: 01 Oct 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
psychotic patients psychotic patients, acute ward, symptom rating scale.	-

Documents available

CSR-NIS-NSE-DUM-2008-1.pdf
Download
CSR-NIS-NSE-DUM-2008-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Sweden Clinical Study Information

+46 8 553 26 000

Investigators

Principal Investigator

Eva Dencker Vansvik

Medical Department